AstraZeneca set to showcase the latest science at ERS Congress 2020
We aim to transform the treatment of respiratory disease with our growing portfolio of inhaled and biologic medicines, along with following the science of common pathways and underlying disease drivers from respiratory disease into immunology-driven disease areas. We look forward to virtually joining clinicians, researchers and scientists at the ERS 2020 Congress to share the latest in Respiratory & Immunology science advancements.
Follow us for updates from the Congress, and join the conversation using #ERSCongress.
Join Our Team
Hear from Chris
"AstraZeneca is a great place to work if you want to be challenged and if you want to have the ability to see the impact of your work towards developing medicines for patients with respiratory diseases like COPD."
Chris Miller - VP, Biometrics & Information Sciences, Respiratory & Immunology
Veeva ID: Z4-26801
Date of Prep: August 2020
Date of Expiry: August 2022